Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 31 December 2025

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

Arcutis Biotherapeutics stock pops today as ARQT bucks biotech dip into year-end trade

NEW YORK, December 31, 2025, 10:33 ET — Regular session Shares of Arcutis Biotherapeutics Inc rose 3.8% to $29.16 by 10:33 a.m. ET on Wednesday, extending gains in the final U.S. trading session of 2025. The Nasdaq-listed dermatology drugmaker traded between $28.08 and $29.19, with about 181,000 shares changing hands. The move puts ARQT within striking distance of $30 and about 8% below its 52-week high of $31.75, a level closely watched by momentum investors. The stock’s 52-week low stands at $11.14, according to market data. markets.businessinsider.com That relative strength mattered on a down day for risk assets. The biotech
31 December 2025
·····
StubHub (STUB) stock ticks up as class-action deadline nears and free-cash-flow questions linger

StubHub (STUB) stock ticks up as class-action deadline nears and free-cash-flow questions linger

NEW YORK, December 31, 2025, 10:00 ET — Regular session StubHub Holdings, Inc. shares were up 0.7% at $14.02 in early New York trading on Wednesday as investors digested a new round of shareholder-law-firm alerts tied to the ticket marketplace’s recent IPO. The notices matter because StubHub’s stock has slid sharply since it began trading in September, keeping legal and disclosure issues in the foreground for a newly public company. They also land as investors focus on cash generation. Free cash flow — the cash a business generates after operating costs and capital spending — is a closely watched yardstick
31 December 2025
·····
DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

DJT stock jumps as Trump Media plans Crypto.com digital tokens for shareholders

NEW YORK, December 31, 2025, 10:02 ET — Regular session Shares of Trump Media & Technology Group Corp. (DJT) rose about 4% on Wednesday after the company said it plans to distribute a new digital token to shareholders in partnership with Crypto.com. The stock was up 3.8% at $13.05 in morning trading, after ranging between $12.52 and $13.47. Reuters The latest crypto-linked plan matters because Trump Media has been leaning into financial products to keep investors engaged and broaden its business beyond its social-media app. Traders have been quick to reprice the stock on product headlines, and the company is
31 December 2025
····
FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

FTAI Aviation stock holds near $200 premarket after FTAI Power data-center turbine pivot

NEW YORK, December 31, 2025, 09:15 ET — Premarket FTAI Aviation Ltd shares were down about 0.5% at $196.72 in premarket trading on Wednesday after the aircraft-engine maintenance group launched a new data-center power initiative. The stock ended the prior session up about 14.4% at $197.68. Investing.com The move follows FTAI’s launch of FTAI Power, which the company said will convert widely used CFM56 jet engines into aeroderivative gas turbines for data centers. “Aeroderivative” is industry shorthand for a turbine derived from an aircraft engine. FTAI said it expects production to begin in 2026 for 25-megawatt units and that it
31 December 2025
·····
Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

Ultragenyx stock today: RARE steadies premarket after setrusumab Phase 3 miss, FDA gene-therapy filing in focus

NEW YORK, December 31, 2025, 09:15 ET — Premarket Ultragenyx Pharmaceutical (RARE.O) shares edged down 0.2% to $22.74 in premarket trading on Wednesday, after finishing Tuesday up 15.5% at $22.78. The stock’s 52-week range is $18.41 to $46.50. StockAnalysis The rare-disease drugmaker is trying to find its footing after a sharp two-day repricing driven by a late-stage clinical setback that hit one of its higher-profile pipeline programs. The next question for investors is whether Ultragenyx can quickly shift attention from a failed bone-disease readout to nearer-term regulatory milestones in gene therapy, while cutting costs to protect cash. Ultragenyx said on
31 December 2025
····
Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

Pfizer stock flat before the bell as report flags 2026 U.S. drug price hikes, including 15% Comirnaty rise

NEW YORK, December 31, 2025, 08:51 ET — Premarket Pfizer Inc shares were little changed in premarket trading on Wednesday after a report showed the drugmaker is leading a new round of U.S. list-price increases for 2026. The stock was down about 0.02% at $24.99, after closing Tuesday at roughly $25.00. The issue matters now because drug pricing has returned to the front burner in Washington, with the Trump administration pressing manufacturers to rein in costs. Year-end is also when many companies set list-price changes that typically take effect in early January. For investors, higher list prices can support revenue
31 December 2025
·····
Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

Ambev stock today: ABEV dips before the bell after Tuesday’s jump — here’s what’s driving it

NEW YORK, December 31, 2025, 08:41 ET — Premarket Ambev S.A. shares were down 0.8% at $2.461 in premarket trading, after ending Tuesday up 2.5% at $2.48. The ADR has traded between $2.28 and $2.60 in recent sessions, reflecting choppy year-end positioning. StockAnalysis The timing matters because late-December trading can amplify small flows, especially in high-yield stocks where investors are repositioning around payouts. For Ambev, the week’s dividend schedule has been the main company-specific marker on screens. Ambev told investors in a U.S. securities filing that its board approved dividends of 0.4612 reais per share, “to be made on December
31 December 2025
····
Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

Applied Digital stock rises premarket as ChronoScale cloud spinout with Ekso draws investor focus

NEW YORK, December 31, 2025, 08:45 ET — Premarket Applied Digital Corporation shares rose about 1% to $24.31 in premarket trading on Wednesday, after a proposed cloud-business spinout kept the AI infrastructure stock in focus. The shares closed Tuesday at $24.08. Investing.com The plan would carve out Applied Digital Cloud and pair it with Nasdaq-listed Ekso Bionics, leaving Applied Digital more exposed to its core data-center development and colocation business. That matters now as investors continue to place a premium on scarce AI computing capacity while questioning how smaller players fund rapid expansion. The proposal also lands at a moment
31 December 2025
······
B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

B2Gold stock today: BTG flat in premarket as gold slips on year-end profit-taking

NEW YORK, December 31, 2025, 08:58 ET — Premarket B2Gold Corp shares were up about 0.1% at $4.56 in premarket trading on Wednesday, little changed from Tuesday’s close. The gold miner tracked a softer tone in bullion prices into the year-end session. The timing matters. Gold miners often trade like a leveraged bet on bullion because revenue is tied to the metal price while many operating costs adjust more slowly. Thin holiday liquidity can make that linkage feel even tighter. Small shifts in gold can translate quickly into equity moves when fewer investors are trading. Spot gold fell 0.9% to
31 December 2025
····
Snap stock dips before the open after CEO Evan Spiegel files to sell 1.26 million shares

Snap stock dips before the open after CEO Evan Spiegel files to sell 1.26 million shares

NEW YORK, December 31, 2025, 08:36 ET — Premarket. Snap Inc (SNAP.N) shares were down about 0.3% in premarket trading on Wednesday, after a regulatory filing detailed a planned share sale tied to co-founder and CEO Evan Spiegel. Yahoo Finance The disclosure lands in the final session of 2025, when trading can be choppy and liquidity thin. In that kind of tape, insider-sale notices can have an outsized impact on sentiment even when they do not change a company’s fundamentals. U.S. stocks ended slightly lower on Tuesday in holiday-thinned trade, and strategists said investors were shifting exposure as the calendar
31 December 2025
·····
Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

Under Armour stock steadies near $5 as Fairfax boosts stake to 16.1%

NEW YORK, December 31, 2025, 07:54 ET — Premarket Under Armour shares held near $5 in premarket indications on Wednesday after filings showed Fairfax Financial Holdings, led by investor V. Prem Watsa, increased its stake in the sportswear maker. Under Armour’s Class A shares (UAA) last closed at $5.14, up about 7.5%, while its Class C shares (UA) ended at $4.93, up about 8.6%. UA Newsroom The disclosure matters because it puts a well-known, deep-pocketed shareholder on the tape at a time when investors have been debating whether Under Armour’s turnaround is stabilizing demand. Large, disclosed buying can also attract
31 December 2025
·····
BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

BigBear.ai stock slides in premarket after company delays key vote to double authorized shares (BBAI)

NEW YORK, December 31, 2025, 07:29 ET — Premarket Shares of BigBear.ai Holdings, Inc. (BBAI) fell 3.2% to $5.50 in premarket trading on Wednesday after the company delayed a shareholder vote on a proposal to double its authorized common stock. The vote would raise the ceiling on how many shares BigBear.ai can issue from 500 million to 1 billion. It does not put new stock into the market by itself, but it gives the board flexibility to sell shares, do stock-based deals or pay employees with equity. That flexibility is in focus because BigBear.ai told investors it is running short
31 December 2025
·····
1 … 893 894 895 896 897 … 1,915

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
Sydney, Feb 7, 2026, 17:39 AEDT — Market closed. South32 Ltd shares (S32.AX) closed down 4.1% at A$4.41 on Friday, hit by the same risk-off wave that pushed Australian miners sharply lower. The stock traded between A$4.37 and A$4.51 and was down 19 cents from the prior close of A$4.60. (Intelligent Investor) With markets shut for the weekend, the move leaves South32 on the watchlist going into Monday’s open as investors reassess exposure to metals and mining names. The S&P/ASX 200 ended the week down 1.81%. (Morningstar) The benchmark fell 2% on Friday and almost A$70 billion was wiped off
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop